DDI Uncovers Your Brand’s Opportunities With Pharma Test Marketing™

Chadds Ford, PA (April 21, 2010) – Are you just asking questions about your brand, or are you really uncovering meaningful patient experiences? This can be the difference between realizing true marketing breakthroughs and just going through the motions to obtain FDA approval. DDI’s Pharma Test Marketing™ service moves beyond clinical trials and quantitative results to provide insights that help position your brand in a compelling manner. The result is marketing materials and messaging that actually resonates with the physicians and patients who use your drugs.

Consider a typical finding from a clinical study:
“The onset of action is within two to three weeks.”
Now consider insight gained from DDI’s Pharma Test Marketing:
“I started to notice the cloud lift after about a week. It didn’t happen all at once, but I felt less tired and wasn’t yelling at my kids as much.”

From a marketing perspective, which means more and proactively uncovers your brand’s opportunities? Immediately after your clinical study is closed, DDI conducts in-depth interviews with the patients enrolled in the trial, study coordinators (the hands-on nurses involved in managing patients during trials), and your investigators to help you realize potential marketing breakthroughs for your brand. Dr. Ross Weaver, president of DDI, remarks, “Our proven process breathes life into clinical data and highlights the real patient experiences that differentiate your brand. It’s DDI’s ability to capture emotive responses from your trial participants that help propel your messaging and marketing strategy.”

Pharma Test Marketing compliments the scientific findings of clinical trials by uncovering participants’ emotive responses that can be leveraged in marketing. Other service highlights include:

• DDI’s methodology is HIPAA compliant market research.
• Their proprietary methodology works with investigators and study coordinators to help recruit patients.
• DDI can hand-pick patients, even in blinded studies, without risking unblinding of the study to the investigative team.
• Can be conducted in nearly every country.
  

About DDI
Drug Development Insights’ industry expertise begins with its president, Dr. Ross Weaver. Dr. Weaver has more than 25 years of experience in the health care field. DDI delivers more than market research and takes pharmaceutical companies inside the minds of group practice and IPA experts to help map out a viable plan for increasing sales and identifying new opportunities. Get the inside scoop on what practice executives are thinking and planning, and embrace the opportunity to approach the market in new, innovative ways to help your brand rise to the top.

To learn more about how DDI delivers insights that drive the success of pharmaceutical brands, contact us today at 877-334-0100 or visit us on the web at www.ddinsights.com.